^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Lung Non-Squamous Non-Small Cell Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + pemetrexed (Thymidylate synthase inhibitor, THF dehydrogenase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/15/2020
Excerpt:
Preferred (Nonsquamous)…useful in certain circumstances…Carboplatin AUC 5 day 1, pemetrexed 500 mg/m2 day 1 for nonsquamous every 21 days for 4 cycles
